Year |
Citation |
Score |
2013 |
Palomo J, Fauconnier M, Coquard L, Gilles M, Meme S, Szeremeta F, Fick L, Franetich JF, Jacobs M, Togbe D, Beloeil JC, Mazier D, Ryffel B, Quesniaux VF. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. European Journal of Immunology. 43: 2683-95. PMID 23780878 DOI: 10.1002/Eji.201343327 |
0.63 |
|
2012 |
Fauconnier M, Palomo J, Bourigault ML, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux VF. IL-12Rβ2 is essential for the development of experimental cerebral malaria. Journal of Immunology (Baltimore, Md. : 1950). 188: 1905-14. PMID 22238458 DOI: 10.4049/Jimmunol.1101978 |
0.605 |
|
2011 |
Fauconnier M, Bourigault ML, Meme S, Szeremeta F, Palomo J, Danneels A, Charron S, Fick L, Jacobs M, Beloeil JC, Ryffel B, Quesniaux VF. Protein kinase C-theta is required for development of experimental cerebral malaria. The American Journal of Pathology. 178: 212-21. PMID 21224058 DOI: 10.1016/J.Ajpath.2010.11.008 |
0.614 |
|
2008 |
Togbe D, de Sousa PL, Fauconnier M, Boissay V, Fick L, Scheu S, Pfeffer K, Menard R, Grau GE, Doan BT, Beloeil JC, Renia L, Hansen AM, Ball HJ, Hunt NH, et al. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. Plos One. 3: e2608. PMID 18612394 DOI: 10.1371/Journal.Pone.0002608 |
0.614 |
|
Show low-probability matches. |